Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Biotium’s new highly-selective stains are designed for both gram-positive and gram-negative bacteria
, /in Product News /by panglobalBiotium, a leading innovator of fluorescent dyes for life science research, has introduced its breakthrough BactoView Dead Stains and BactoView Viability Kits. These products were carefully designed for easy usage and improved dead cell selectivity for enhanced microbial viability determination. With precise dead cell detection being vital for accurate analysis, Biotium’s BactoView Dead Stains deliver […]
Bio-Rad launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
, /in Product News /by panglobalBio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, has launched its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.
New Micro Flow Meter from Biotech Fluidics designed to monitor ultra-low fluidic flows
, /in Product News /by panglobalThe Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.
Fapon and Halodoc forge strategic partnership to drive the development of Indonesia’s in-vitro diagnostics Industry
, /in E-News /by panglobalGuangdong, China-based Fapon, a global life-science and biotech company, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform in Indonesia. This partnership brings together Fapon’s expertise in in-vitro diagnostics (IVD) technologies and integrated solutions with Halodoc’s strong sales channels and local service provisions. The partnership aims to enhance the healthcare standards in Indonesia, […]
Semarion announces early adopter programme for SemaCyte Microcarrier Platform
, /in E-News /by panglobalSemarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced the opening of its Early Adopter Programme for its SemaCyte Microcarrier Platform. The platform overcomes current limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells […]
The PolG Foundation awards over $3.5m in academic grants to pioneer POLG research
, /in E-News /by panglobalThe PolG Foundation is a nascent foundation established in 2022, with the mission to support and accelerate research to find effective treatments and a cure for PolG mitochondrial disorders. Among many activities, one central pillar of the foundation is to raise funding and provide grants to world-class investigators of basic science, clinical trial research and […]
Hermes Pharma to invest € 25 million to bolster manufacturing capabilities for oral dosage forms
, /in E-News /by panglobalGermany-based Hermes Pharma, a leading expert in user-friendly oral dosage forms, has announced it will invest €25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. As […]
CN Bio appoints Neil Rumbelow as director of product development
, /in E-News /by panglobalCN Bio, a leading UK Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems, has appointed Neil Rumbelow as director of product development.
Thermo Fisher plans to expand into proteomics with Olink acquisition
, /in E-News /by panglobalFollowing agreement by the respective boards of directors, Thermo Fisher Scientific in mid-October announced plans to acquire Olink Holding for US$3.1 billion. The acquisition will enable Thermo Fisher to expand into proteomics and complement its platforms in life sciences and mass spectrometry. Olink offers solutions for advanced proteomics discovery and development.
New cleanrooms prompt search for better monitoring system
, /in E-News /by panglobalDuring preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring and control procedures, and decided to switch to a new Vaisala system, including almost 150 monitoring locations within cleanrooms and associated facilities.